The FDA authorizes hospitals to use ivermectin for COVID-19.

[kafa88]

the Food and Drug Administration (FDA) issued a special license to allow hospitals to use ivermectin for COVID-19 patients.FDA Director Eric Domingo said the drug is now the subject of clinical trials to validate its efficacy. “Ivermectin is a research product and we know that there are ongoing clinical trials involved in the clinical trials. Using COVID-19, ”he said at Malacanang's Laging Handa briefing.

Domingo cited the slotxo download privacy of patients in refusing to disclose the names of hospitals applying for sympathetic use licenses.The attending physician has full responsibility for the use of this product," he said in a Viber message.Many doctors advocate the use of ivermectin (or USP grade) for the prevention and treatment of an unprecedented increase in COVID-19 in the country.But the Department of Health (DOH) and the FDA quickly shut down this option,

saying there are still lack of studies to prove its use reduces mortality or improves. "Other clinically important results"Still, heads of businesses and other organizations recently issued an open letter to President Duterte and Congress leaders calling for "serious, urgent and immediate attention to ivermectin as an affordable drug in the prevention and treatment of COVID-". 19 during this public health crisis.


For unregistered drugs

A special sympathetic license is granted for the use of drugs that are not registered or still in the process of registering in the country.Domingo said the FDA has also received two applications for the product registration certificate for ivermectin and has provided applicants with a list of requirements to support the application.The FDA often says it is not against ivermectin," he said, "but the product must be registered and processed appropriately to ensure the quality of the drug to be delivered to the public.

The Philippines-registered ivermectin product is currently for veterinary use.Jacinto Blas Mantaring, chair of the clinical epidemiology department at the University of the Philippine College of Medicine, said on the forum that there is a need for clinical trials on the use of ivermectin on COVID-19 patients.Mantaring said in an online forum hosted by Philippine-American Academy of Science and Engineering (PAASE) Mantaring said he studied 11 trials and saw no evidence indicating

the drug's efficacy for treatment and prevention.Waiting for the trial results"In the same PAASE forum,which was published online on March 31, Dr Benigno Akbayani, president of the Philippine physician and concerned citizen, said that in the case of an emergency on the island of Ko-kin, ivermectin should be considered appropriately.Agbayani said the drug was "nullified" as a result of the Philippines' slow release of the COVID-19 vaccination drive.